APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anti-Diabetic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Anti-Diabetic Drug Industry Growth and Trends Forecast to 2032

2 January 2026106 pages

Choose your research edition.

Industry ResearchOral Anti-Diabetic Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anti-Diabetic Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Oral Anti-Diabetic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anti-Diabetic Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anti-Diabetic Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Oral Anti-Diabetic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Anti-Diabetic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Anti-Diabetic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Anti-Diabetic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Anti-Diabetic Drug include Astellas, Biocon, Boehringer Ingelheim, Bristol Myers Squibb, Merck And Co., AstraZeneca, Pfizer, Eli Lilly and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Anti-Diabetic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Anti-Diabetic Drug market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Anti-Diabetic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Anti-Diabetic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Anti-Diabetic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Anti-Diabetic Drug Market by Company

Astellas

Biocon

Boehringer Ingelheim

Bristol Myers Squibb

Merck And Co.

AstraZeneca

Pfizer

Eli Lilly

Novartis

Sanofi

Takeda

Abbott

Janssen Pharmaceuticals

Oral Anti-Diabetic Drug Segment by Type

Gliclazide

Glimepiride

Glyburide

Others

Oral Anti-Diabetic Drug Segment by Application

Hospital

Research Institual

Oral Anti-Diabetic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anti-Diabetic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anti-Diabetic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anti-Diabetic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Anti-Diabetic Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Anti-Diabetic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gliclazide Table 2. Major Company of Glimepiride Table 3. Major Company of Glyburide Table 4. Major Company of Others Table 5. Global Oral Anti-Diabetic Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 7. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Oral Anti-Diabetic Drug Price by Type (2021-2026) & (US$/Ton) Table 11. Global Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 12. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Oral Anti-Diabetic Drug Price by Type (2027-2032) & (US$/Ton) Table 16. North America Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 17. North America Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 19. Europe Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 23. Latin America Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Oral Anti-Diabetic Drug Industry Trends Table 27. Oral Anti-Diabetic Drug Industry Drivers Table 28. Oral Anti-Diabetic Drug Industry Opportunities and Challenges Table 29. Oral Anti-Diabetic Drug Industry Restraints Table 30. Global Oral Anti-Diabetic Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Oral Anti-Diabetic Drug Revenue Market Share by Company (2021-2026) Table 32. Global Oral Anti-Diabetic Drug Sales by Company (2021-2026) & (Tons) Table 33. Global Oral Anti-Diabetic Drug Sales Share by Company (2021-2026) Table 34. Global Oral Anti-Diabetic Drug Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Oral Anti-Diabetic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Oral Anti-Diabetic Drug Major Company Production Sites and Headquarters Table 37. Global Oral Anti-Diabetic Drug Company, Product Type & Application Table 38. Global Oral Anti-Diabetic Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Oral Anti-Diabetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Oral Anti-Diabetic Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Oral Anti-Diabetic Drug Sales by Region (2021-2026) & (Tons) Table 43. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Oral Anti-Diabetic Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Oral Anti-Diabetic Drug Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Oral Anti-Diabetic Drug Sales by Region (2027-2032) & (Tons) Table 48. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Oral Anti-Diabetic Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Oral Anti-Diabetic Drug Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Oral Anti-Diabetic Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 54. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Oral Anti-Diabetic Drug Price by Application (2021-2026) & (US$/Ton) Table 58. Global Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 59. Global Oral Anti-Diabetic Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Oral Anti-Diabetic Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Oral Anti-Diabetic Drug Price by Application (2027-2032) & (US$/Ton) Table 63. North America Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 64. North America Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 66. Europe Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 70. Latin America Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Astellas Company Information Table 74. Astellas Business Overview Table 75. Astellas Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Astellas Oral Anti-Diabetic Drug Product Portfolio Table 77. Astellas Recent Development Table 78. Biocon Company Information Table 79. Biocon Business Overview Table 80. Biocon Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Biocon Oral Anti-Diabetic Drug Product Portfolio Table 82. Biocon Recent Development Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Oral Anti-Diabetic Drug Product Portfolio Table 87. Boehringer Ingelheim Recent Development Table 88. Bristol Myers Squibb Company Information Table 89. Bristol Myers Squibb Business Overview Table 90. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Bristol Myers Squibb Oral Anti-Diabetic Drug Product Portfolio Table 92. Bristol Myers Squibb Recent Development Table 93. Merck And Co. Company Information Table 94. Merck And Co. Business Overview Table 95. Merck And Co. Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Merck And Co. Oral Anti-Diabetic Drug Product Portfolio Table 97. Merck And Co. Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. AstraZeneca Oral Anti-Diabetic Drug Product Portfolio Table 102. AstraZeneca Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Pfizer Oral Anti-Diabetic Drug Product Portfolio Table 107. Pfizer Recent Development Table 108. Eli Lilly Company Information Table 109. Eli Lilly Business Overview Table 110. Eli Lilly Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Eli Lilly Oral Anti-Diabetic Drug Product Portfolio Table 112. Eli Lilly Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Novartis Oral Anti-Diabetic Drug Product Portfolio Table 117. Novartis Recent Development Table 118. Sanofi Company Information Table 119. Sanofi Business Overview Table 120. Sanofi Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Sanofi Oral Anti-Diabetic Drug Product Portfolio Table 122. Sanofi Recent Development Table 123. Takeda Company Information Table 124. Takeda Business Overview Table 125. Takeda Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Takeda Oral Anti-Diabetic Drug Product Portfolio Table 127. Takeda Recent Development Table 128. Abbott Company Information Table 129. Abbott Business Overview Table 130. Abbott Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Abbott Oral Anti-Diabetic Drug Product Portfolio Table 132. Abbott Recent Development Table 133. Janssen Pharmaceuticals Company Information Table 134. Janssen Pharmaceuticals Business Overview Table 135. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Portfolio Table 137. Janssen Pharmaceuticals Recent Development Table 138. North America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 139. North America Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 140. North America Oral Anti-Diabetic Drug Sales Market Share by Country (2021-2026) Table 141. North America Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032) & (Tons) Table 142. North America Oral Anti-Diabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 143. North America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Oral Anti-Diabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Oral Anti-Diabetic Drug Market Share by Country (2021-2026) Table 146. North America Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Oral Anti-Diabetic Drug Market Share Forecast by Country (2027-2032) Table 148. Europe Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 149. Europe Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 150. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2021-2026) Table 151. Europe Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032) & (Tons) Table 152. Europe Oral Anti-Diabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Oral Anti-Diabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Oral Anti-Diabetic Drug Market Share by Country (2021-2026) Table 156. Europe Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Oral Anti-Diabetic Drug Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 160. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032) & (Tons) Table 162. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Oral Anti-Diabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Oral Anti-Diabetic Drug Market Share by Country (2021-2026) Table 166. Asia-Pacific Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Oral Anti-Diabetic Drug Market Share Forecast by Country (2027-2032) Table 168. Latin America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 169. Latin America Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 170. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country (2021-2026) Table 171. Latin America Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032) & (Tons) Table 172. Latin America Oral Anti-Diabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Oral Anti-Diabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Oral Anti-Diabetic Drug Market Share by Country (2021-2026) Table 176. Latin America Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Oral Anti-Diabetic Drug Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 180. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032) & (Tons) Table 182. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Oral Anti-Diabetic Drug Market Share by Country (2021-2026) Table 186. Middle East and Africa Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Oral Anti-Diabetic Drug Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Oral Anti-Diabetic Drug Distributors List Table 191. Oral Anti-Diabetic Drug Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Oral Anti-Diabetic Drug Image Figure 2. Global Oral Anti-Diabetic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anti-Diabetic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Anti-Diabetic Drug Sales (2021-2032) & (Tons) Figure 5. Gliclazide Image Figure 6. Global Gliclazide Sales YoY Growth (2021-2032) & (Tons) Figure 7. Glimepiride Image Figure 8. Global Glimepiride Sales YoY Growth (2021-2032) & (Tons) Figure 9. Glyburide Image Figure 10. Global Glyburide Sales YoY Growth (2021-2032) & (Tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Oral Anti-Diabetic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Oral Anti-Diabetic Drug Market Share by Type 2025 VS 2032 Figure 15. North America Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Oral Anti-Diabetic Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 29. Research Institual Image Figure 30. Global Research Institual Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Oral Anti-Diabetic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Oral Anti-Diabetic Drug Market Share by Application 2025 VS 2032 Figure 33. North America Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Oral Anti-Diabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Oral Anti-Diabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Oral Anti-Diabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Oral Anti-Diabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oral Anti-Diabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Oral Anti-Diabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oral Anti-Diabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Oral Anti-Diabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oral Anti-Diabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Oral Anti-Diabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oral Anti-Diabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Oral Anti-Diabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oral Anti-Diabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Oral Anti-Diabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oral Anti-Diabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Oral Anti-Diabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Oral Anti-Diabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Oral Anti-Diabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Oral Anti-Diabetic Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Oral Anti-Diabetic Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gliclazide
  • Glimepiride
  • Glyburide
  • Others
Applications
  • Hospital
  • Research Institual
Companies covered
  • Astellas
  • Biocon
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Merck And Co.
  • AstraZeneca
  • Pfizer
  • Eli Lilly
  • Novartis
  • Sanofi
  • Takeda
  • Abbott
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Anti-Diabetic Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Anti-Diabetic Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Anti-Diabetic Drug Market by Type
  6. 1.3.1 Gliclazide
  7. 1.3.2 Glimepiride
  8. 1.3.3 Glyburide
  9. 1.3.4 Others
  10. 1.4 Global Oral Anti-Diabetic Drug Market Size by Type
  11. 1.4.1 Global Oral Anti-Diabetic Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Oral Anti-Diabetic Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Oral Anti-Diabetic Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Oral Anti-Diabetic Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Oral Anti-Diabetic Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Oral Anti-Diabetic Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Oral Anti-Diabetic Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Oral Anti-Diabetic Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Anti-Diabetic Drug Industry Trends
  2. 2.2 Oral Anti-Diabetic Drug Industry Drivers
  3. 2.3 Oral Anti-Diabetic Drug Industry Opportunities and Challenges
  4. 2.4 Oral Anti-Diabetic Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Anti-Diabetic Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Anti-Diabetic Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Anti-Diabetic Drug Price (2021-2026)
  4. 3.4 Global Oral Anti-Diabetic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Anti-Diabetic Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Anti-Diabetic Drug Company, Product Type & Application
  7. 3.7 Global Oral Anti-Diabetic Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Anti-Diabetic Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Anti-Diabetic Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Anti-Diabetic Drug Tier 1, Tier 2, and Tier 3
4 Oral Anti-Diabetic Drug Regional Status and Outlook
  1. 4.1 Global Oral Anti-Diabetic Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Anti-Diabetic Drug Historic Market Size by Region
  3. 4.2.1 Global Oral Anti-Diabetic Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Anti-Diabetic Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Anti-Diabetic Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Anti-Diabetic Drug Forecasted Market Size by Region
  7. 4.3.1 Global Oral Anti-Diabetic Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Anti-Diabetic Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Anti-Diabetic Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Anti-Diabetic Drug by Application
  1. 5.1 Oral Anti-Diabetic Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institual
  4. 5.2 Global Oral Anti-Diabetic Drug Market Size by Application
  5. 5.2.1 Global Oral Anti-Diabetic Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral Anti-Diabetic Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral Anti-Diabetic Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral Anti-Diabetic Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral Anti-Diabetic Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral Anti-Diabetic Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral Anti-Diabetic Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral Anti-Diabetic Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Astellas
  2. 6.1.1 Astellas Company Information
  3. 6.1.2 Astellas Business Overview
  4. 6.1.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Astellas Oral Anti-Diabetic Drug Product Portfolio
  6. 6.1.5 Astellas Recent Developments
  7. 6.2 Biocon
  8. 6.2.1 Biocon Company Information
  9. 6.2.2 Biocon Business Overview
  10. 6.2.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biocon Oral Anti-Diabetic Drug Product Portfolio
  12. 6.2.5 Biocon Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Bristol Myers Squibb
  20. 6.4.1 Bristol Myers Squibb Company Information
  21. 6.4.2 Bristol Myers Squibb Business Overview
  22. 6.4.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Product Portfolio
  24. 6.4.5 Bristol Myers Squibb Recent Developments
  25. 6.5 Merck And Co.
  26. 6.5.1 Merck And Co. Company Information
  27. 6.5.2 Merck And Co. Business Overview
  28. 6.5.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck And Co. Oral Anti-Diabetic Drug Product Portfolio
  30. 6.5.5 Merck And Co. Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Oral Anti-Diabetic Drug Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Oral Anti-Diabetic Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Oral Anti-Diabetic Drug Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Oral Anti-Diabetic Drug Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Oral Anti-Diabetic Drug Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 Takeda
  62. 6.11.1 Takeda Company Information
  63. 6.11.2 Takeda Business Overview
  64. 6.11.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Takeda Oral Anti-Diabetic Drug Product Portfolio
  66. 6.11.5 Takeda Recent Developments
  67. 6.12 Abbott
  68. 6.12.1 Abbott Company Information
  69. 6.12.2 Abbott Business Overview
  70. 6.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbott Oral Anti-Diabetic Drug Product Portfolio
  72. 6.12.5 Abbott Recent Developments
  73. 6.13 Janssen Pharmaceuticals
  74. 6.13.1 Janssen Pharmaceuticals Company Information
  75. 6.13.2 Janssen Pharmaceuticals Business Overview
  76. 6.13.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Portfolio
  78. 6.13.5 Janssen Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Oral Anti-Diabetic Drug Sales by Country
  2. 7.1.1 North America Oral Anti-Diabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Anti-Diabetic Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Anti-Diabetic Drug Market Size by Country
  6. 7.2.1 North America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Anti-Diabetic Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Anti-Diabetic Drug Sales by Country
  2. 8.1.1 Europe Oral Anti-Diabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Anti-Diabetic Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Anti-Diabetic Drug Market Size by Country
  6. 8.2.1 Europe Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Anti-Diabetic Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Anti-Diabetic Drug Sales by Country
  2. 9.1.1 Asia-Pacific Oral Anti-Diabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Anti-Diabetic Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Anti-Diabetic Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Anti-Diabetic Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Anti-Diabetic Drug Sales by Country
  2. 10.1.1 South America Oral Anti-Diabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Anti-Diabetic Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Anti-Diabetic Drug Market Size by Country
  6. 10.2.1 South America Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Anti-Diabetic Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country
  2. 11.1.1 Middle East and Africa Oral Anti-Diabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Anti-Diabetic Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Anti-Diabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Anti-Diabetic Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Anti-Diabetic Drug Value Chain Analysis
  2. 12.1.1 Oral Anti-Diabetic Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Anti-Diabetic Drug Production Mode & Process
  7. 12.2 Oral Anti-Diabetic Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Anti-Diabetic Drug Distributors
  10. 12.2.3 Oral Anti-Diabetic Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst